Clifford Chance advises Cinven on its £2.3bn of sale of AMCo to Concordia
Clifford Chance advised leading European private equity firm Cinven on its £2.3bn sale of Amdipharm Mercury Company Limited (AMCo), the niche specialty pharmaceuticals group, to TSX/Nasdaq-listed Concordia Healthcare Corporation (Concordia).